A Rare Case of Homocysteinemia Presenting With Multiple Aneurysms in an Adolescent Boy

Ali Hamza1, Anum Arif2, Ahsin Manzoor Bhatti2

  • 1Internal Medicine, Combined Military Hospital, Lahore, PAK.

Cureus
|October 18, 2021
PubMed

Insights

Thoracic aortic aneurysms are rare in children but can be fatal. This case highlights a rare pediatric presentation of thoracoabdominal aortic aneurysm (TAAA) type IV, linked to homocysteinemia.

Area of Science:

  • Cardiovascular Medicine
  • Pediatric Cardiology
  • Medical Genetics

Background:

  • Thoracoabdominal aortic aneurysm (TAAA) is a rare condition in children, often leading to misdiagnosis.
  • TAAA is a significant cause of mortality in the elderly, with a higher incidence in males.
  • Limited data exists on the prevalence and specific causes of aortic aneurysms in pediatric populations.

Observation:

  • A case study of an adolescent male presenting with complex cardiovascular issues.
  • The patient exhibited a left coronary artery aneurysm, left axillary artery aneurysm, and TAAA type IV.
  • These vascular abnormalities were attributed to the metabolic disorder homocysteinemia.

Findings:

  • Homocysteinemia can manifest as severe, multi-site arterial aneurysms in adolescents.
  • This case underscores the importance of considering metabolic disorders in pediatric aneurysm etiology.
  • The diagnostic journey involved identifying a rare combination of aneurysms in a young patient.

Implications:

  • Early diagnosis and management of homocysteinemia are crucial to prevent life-threatening aortic complications in children.
  • This case expands the understanding of TAAA in pediatric populations, emphasizing rare underlying causes.
  • Highlights the need for comprehensive screening in pediatric patients with unexplained arterial aneurysms.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
48
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
41
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
54
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
262